SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-024260
Filing Date
2023-03-30
Accepted
2023-03-29 21:56:55
Documents
84
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_cadrenalth.htm   iXBRL 10-K 1434624
2 DESCRIPTION OF SECURITIES f10k2022ex4-11_cadrenal.htm EX-4.11 28401
3 SUBSIDIARIES OF REGISTRANT f10k2022ex21-1_cadrenal.htm EX-21.1 1013
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2022ex23-1_cadrenal.htm EX-23.1 2530
5 CERTIFICATION f10k2022ex31-1_cadrenal.htm EX-31.1 13170
6 CERTIFICATION f10k2022ex31-2_cadrenal.htm EX-31.2 13205
7 CERTIFICATION f10k2022ex32-1_cadrenal.htm EX-32.1 5587
8 CERTIFICATION f10k2022ex32-2_cadrenal.htm EX-32.2 5110
9 GRAPHIC image_001.jpg GRAPHIC 12285
10 GRAPHIC image_002.jpg GRAPHIC 19008
11 GRAPHIC image_003.jpg GRAPHIC 15882
12 GRAPHIC image_004.jpg GRAPHIC 9251
13 GRAPHIC image_005.jpg GRAPHIC 13660
14 GRAPHIC image_006.jpg GRAPHIC 18305
15 GRAPHIC image_007.jpg GRAPHIC 10827
  Complete submission text file 0001213900-23-024260.txt   5829546

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE cvkd-20221231.xsd EX-101.SCH 53761
17 XBRL CALCULATION FILE cvkd-20221231_cal.xml EX-101.CAL 31370
18 XBRL DEFINITION FILE cvkd-20221231_def.xml EX-101.DEF 253879
19 XBRL LABEL FILE cvkd-20221231_lab.xml EX-101.LAB 495209
20 XBRL PRESENTATION FILE cvkd-20221231_pre.xml EX-101.PRE 270833
78 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_cadrenalth_htm.xml XML 409113
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41596 | Film No.: 23776979
SIC: 2834 Pharmaceutical Preparations